Related Experiment Video

Updated: May 1, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K

HIV cure after HCT: seven horses seem to be on the mark

Jose F Camargo1

  • 1University of Miami Miller School of Medicine, Miami, Florida, United States.

Blood Advances
|April 29, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

14.1K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

7.6K

Related Experiment Videos

Last Updated: May 1, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

14.1K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

7.6K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Hepatitis01:25

Hepatitis

86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86

Articles linked to this work by shared authors, journal, and citation graph.

Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience.

Cureus·2026

Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.

Mycopathologia·2026

Routine Screening of Strongyloides Among Patients With Lymphoma and Efficacy of Targeted Prophylaxis.

American journal of hematology·2025

"What am I?" microbiology of culture-positive, biofire® blood culture identification 2 panel-negative bloodstream infections.

Diagnostic microbiology and infectious disease·2025

Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy.

Blood advances·2024

MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.

Clinical microbiology reviews·2023

The SF3b complex in cancer: structural basis, molecular mechanisms, and therapeutic opportunities.

Blood advances·2026

Prognostic value of measuring LSC frequency in AML: a systematic review and meta-analysis.

Blood advances·2026

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

Blood advances·2026

The hematology workforce in the United States: past, present, and strategies for the future.

Blood advances·2026

Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.

Blood advances·2026

Modifying quality and equity of care: emerging roles of genetic disease modifiers in β-hemoglobinopathies.

Blood advances·2026

Comparison of urodynamic outcomes by hysterectomy technique: A cross-sectional study.

Urologia·2026

Correction: Supplementation of Saussurea costus root alleviates sodium nitrite-induced hepatorenal toxicity by modulating metabolic profile, inflammation, and apoptosis.

Frontiers in pharmacology·2026

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.

Gout, urate, and crystal deposition disease·2026

Computational analysis of therapeutic potential for simplified Piper spp.- derived medicinal mixtures in anxiety, sleep, pain and seizure.

Frontiers in pharmacology·2026

Decoction-derived bioactive nanoparticles of Lycopodium japonicum Thunb. attenuate knee osteoarthritis by regulating MAPK/ERK signaling.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Isolinderalactone alleviates hepatic ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress through the SIRT1/IRE1α signaling pathway.

International immunopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us